GeoPharma, Inc. Announces Settlement of Clarinex(r) (Desloratadine) ANDA Patent Litigation With Schering Corporation and Sepracor, Inc.

Published: Jan 20, 2009

LARGO, Fla., Jan. 20, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it has reached agreement with the Schering Corporation ("Schering"), and Sepracor, Inc. and the University of Massachusetts (collectively, "Sepracor") settling all Hatch-Waxman litigation relating to Desloratadine tablets (5 mg), with the Company receiving a license under all relevant patents.

Back to news